Get started
Award

MR/S021949/1

Funded outputs count: 68
Funder award ID: MR/S021949/1
OpenAlex ID: G1897664285
A scoping review of the measurement and analysis of frailty in randomised controlled trials
2024 · Yanhe Sun, Miles D Witham, et al. · Age and Ageing · 17
PDF
Frailty and socioeconomic position: A systematic review of observational studies
2024 · Peter Hanlon, Marina Politis, et al. · Ageing Research Reviews · 81
Participant characteristics and exclusion from phase 3/4 industry funded trials of chronic medical conditions: meta-analysis of individual participant level data
2024 · Jennifer Lees, Jamie Crowther, et al. · BMJ Medicine · 3
PDF
An observational analysis of frailty in combination with loneliness or social isolation and their association with socioeconomic deprivation, hospitalisation and mortality among UK Biobank participants
2024 · Marina Politis, Lynsay Crawford, et al. · Scientific Reports · 17
PDF
The relationship between frailty and social vulnerability: a systematic review
2024 · Peter Hanlon, Heather Wightman, et al. · The Lancet Healthy Longevity · 146
Constructing a quality frailty index: you get out what you put in
2024 · Peter Hanlon, Silje A Welsh, et al. · Age and Ageing · 8
PDF
Personalised lung cancer risk stratification and lung cancer screening: do general practice electronic medical records have a role?
2023 · Bhautesh Dinesh Jani, Michael K. Sullivan, et al. · British Journal of Cancer · 5
PDF
Recent developments in frailty identification, management, risk factors and prevention: A narrative review of leading journals in geriatrics and gerontology
2023 · Elsa Dent, Peter Hanlon, et al. · Ageing Research Reviews · 134
Correlations between comorbidities in trials and the community: An individual-level participant data meta-analysis
2023 · Jamie Crowther, Elaine W Butterly, et al. · Journal of Multimorbidity and Comorbidity · 1
PDF
Frailty in randomised controlled trials for dementia or mild cognitive impairment measured via the frailty index: prevalence and prediction of serious adverse events and attrition
2023 · Heather Wightman, Terry J. Quinn, et al. · Alzheimer s Research & Therapy · 14
PDF
Treatment effect modification due to comorbidity: Individual participant data meta-analyses of 120 randomised controlled trials
2023 · Peter Hanlon, Elaine W. Butterly, et al. · PLoS Medicine · 22
Assessing treatment effect modification due to comorbidity using individual participant data from industry-sponsored drug trials
2023 · Peter Hanlon, Elaine W Butterly, et al. · medRxiv
PDF
Comorbidity and health-related quality of life in people with a chronic medical condition in randomised clinical trials: An individual participant data meta-analysis
2023 · Elaine W. Butterly, Peter Hanlon, et al. · PLoS Medicine · 30
Prevalence, measurement, and implications of frailty in stroke survivors: An analysis of three global aging cohorts
2023 · Peter Hanlon, Jennifer K Burton, et al. · International Journal of Stroke · 35
Systematic review and meta-analysis of prevalence, trajectories, and clinical outcomes for frailty in COPD
2023 · Peter Hanlon, Xuetong Guo, et al. · npj Primary Care Respiratory Medicine · 44
PDF
Assessing Representativeness of Randomised Controlled Trials using Serious Adverse Events
2023 · Peter Hanlon, Sofia Dias, et al. · Big Data
PDF
The presence and impact of multimorbidity clusters on adverse outcomes across the spectrum of kidney function
2022 · Michael K. Sullivan, Juan-Jesus Carrero, et al. · BMC Medicine · 16
PDF
Assessing trial representativeness using serious adverse events: an observational analysis using aggregate and individual-level data from clinical trials and routine healthcare data
2022 · Peter Hanlon, Elaine Butterly, et al. · BMC Medicine · 10
PDF
Frailty in people with rheumatoid arthritis: a systematic review of observational studies
2022 · Peter Hanlon, Holly Morrison, et al. · Wellcome Open Research · 16
Effect of age, sex, and morbidity count on trial attrition: meta-analysis of individual participant level data from phase 3/4 industry funded clinical trials
2022 · Jennifer S Lees, Peter Hanlon, et al. · BMJ Medicine · 24
PDF
Frailty in COPD: an analysis of prevalence and clinical impact using UK Biobank
2022 · Peter Hanlon, James Lewsey, et al. · BMJ Open Respiratory Research · 59
PDF
P096 Analysis of frailty in rheumatoid arthritis and its relationship with disease activity, hospitalization and mortality: findings from the Scottish Early Rheumatoid Arthritis cohort and UK Biobank
2022 · Peter Hanlon, Fraser Morton, et al. · Lara D. Veeken
Representativeness of antihypertensive trials: analysis of serious adverse events
2022 · Peter Hanlon, ANOOP SHAH, et al. · Hypertension · 1
PDF
Use of race in family medicine research publications
2022 · John Westfall, Yalda Jabbarpour, et al.
PDF
Multimorbidity and frailty in middle-aged adults with type 2 diabetes mellitus
2022 · Peter Hanlon, Bhautesh Jani, et al. · 5
PDF
Year
Topic